334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more
Peter Attia MD
An early hydrophilic statin, contrasted with simvastatin, and was anecdotally considered safer due to early beliefs about its reduced ability to cross the blood-brain barrier, though later research suggests all statins cross.
